About Us

EBANZER began its journey in 2015, providing professional support across multiple neurophysiology departments. With a strong focus on technical expertise and healthcare collaboration, the company steadily expanded its services across hospitals in South India.

In 2017, EBANZER became GST registered, formally establishing its operations and strengthening its presence in the healthcare technology sector. During the period from 2017 to 2020, EBANZER partnered with Cadwell, a US-based neurodiagnostic technology company, playing a key role in introducing advanced neurophysiology solutions to hospitals in India.

In 2018, the company further expanded its footprint by developing a franchise network across South India and establishing dedicated marketing and biomedical engineering teams to enhance service delivery.

A major milestone came in 2020 with the establishment of EBANZER’s Research and Development division, marking a shift towards the development and production of neurological products.

Continuing its growth trajectory, EBANZER initiated the manufacturing of CAP (Conductive Adhesive Paste) in 2025, followed by the production of NEWRAB, a neurological support product, in 2026

150+

15

Trusted Globally

10+ Centers